1.A Case of Trensient Myeloproliferative Disorder with Down Syndrome.
Dong Gyoon KIM ; Jae Ho LEE ; Jung Il NOH ; Hyo Seop AHN ; Chang Yee HONG
Journal of the Korean Pediatric Society 1983;26(10):1024-1028
No abstract available.
Down Syndrome*
;
Myeloproliferative Disorders*
2.Clinical considerations of acute leukemia or transient myeloprolifo- rative disorder in Down syndrome.
Eun Sil DONG ; Sung Hee JANG ; Hong Hoe KOO ; Hye Lim JUNG ; Hee Young SHIN ; Hyo Seop AHN
Journal of the Korean Pediatric Society 1991;34(1):74-82
No abstract available.
Down Syndrome*
;
Leukemia*
3.Acute megakaryoblastic leukemia in children.
Hong Hoe KOO ; Eun Sil DONG ; Hye Jung PARK ; Hee Young SHIN ; Hyo Seop AHN ; Sang Kyu PARK
Journal of the Korean Pediatric Society 1993;36(1):9-16
We analyzed the clinical and laboratory features of ten children with acute megakaryoblastic lukemia (M7)and compared the findings with those reported in the literature. The diagnosis was supprted by ultrastructural examination of platelet peroxidase or immunophenotyping for glycoprotein IIb/IIIa. Of the ten children, five were girls and five were boys. The median age at diagnosis was 13 months. Two patients had prominent myelofibrosis and one patient had Down syndrome. Nine patients were treatd with low-dose cytosine arabinoside (10mg/m2)administered intravenously, or subcutaneously, or intramuscularly, twice daily in 21 day courses. Seven patients achieved hematologic response and three patients are alive without evidence of disease. The 4 year event free survival rate was30.0%. It is our impression that the prevalence of acute megakaryoblastic leukemia has been under-estimated, and low-dose cytosine arabinoside treatment may be of value in its management. This approach may be particularily useful in hospitals with scarce well-equipped facilities, since this protocol does not induce profound marrow hypoplasia and intensive supportive measures are not required as they would be with the use of more aggressive drug combination.
Blood Platelets
;
Bone Marrow
;
Child*
;
Cytarabine
;
Diagnosis
;
Disease-Free Survival
;
Down Syndrome
;
Female
;
Glycoproteins
;
Humans
;
Immunophenotyping
;
Leukemia, Megakaryoblastic, Acute*
;
Megakaryocyte Progenitor Cells
;
Peroxidase
;
Prevalence
;
Primary Myelofibrosis
4.Identification of Acinetobacter calcoaceticus - Acinetobacter baumannii Complex by Ribotyping.
Dong Taek CHO ; Je Chul LEE ; Jung Min KIM ; Haeng Seop SHIN ; Hee Kyung CHANG ; Su Yul AHN
Journal of the Korean Society for Microbiology 1998;33(6):605-617
Acinetobacter species encounters frequently with clinical specimens and now accounts for a substantial proportion of endemic nosocomial infections in Korea. Recent trends indicate that the antimicrobial resistant strains of Acinetobacter species are increasing. Sixty-one strains were isolated from specimens of patients suspected of nosocomial infections during 1991 to 1996. At present, phenotypic identification of Acinetobacter using biochemical test may not be reliable and resulted in the difficulty to clarify the source of infections and epidemiological study of hospital-acquired infections. Aware of the importance of rational taxonomic proposal for these isolates, correct species identification of these organisms by molecular typing method was carried out. A total of fifty-four strains of A. calcoaceticus-A. baumannii complex species which were identified to genospecies 2 and 13 by biochemical characteristics was subjected to identify by ribotyping using restriction endonuclease EcoRI, ClaI, and SalI. Of fifty-four strains, twenty-five strains were identified as A. baumannii (genospecies 2) and twenty-one strains as genospecies 13, and six strains changed to genospecies 3, and the rest two strains were confirmed as A. haemolyticus (genospecies 4). This result suggests that the ribotyping may be of value for identification of genospecies and epidemiological information of Acinetobacter strains.
Acinetobacter baumannii*
;
Acinetobacter calcoaceticus*
;
Acinetobacter*
;
Cross Infection
;
DNA Restriction Enzymes
;
Humans
;
Korea
;
Molecular Typing
;
Ribotyping*
5.Differences in Serum CEA Level between Colon and Rectal Cancer.
Woon Seop SONG ; Ho Jin JUN ; Dong Kook PARK ; Chan Young LEE ; Jung Tak KIM ; Doo Sun LEE ; Min JUNG ; Jong Kwon PARK ; Jin Woo RHU
Journal of the Korean Society of Coloproctology 1998;14(3):393-398
We investigated whether there is differences in serum level of carcinoembryonic antigen (CEA) between patients with colon and rectal cancer. Preoperative serum levels of CEA was determined in 65 patients with colon cancer and in 88 patients with rectal cancer. Cut-off value recommended by manufacturers is 5 ng/ml for CEA. At the recommended cut-off levels for CEA, overall sensitivity of CEA was 43.1 percent for colon and 42.0 percent for rectal cancer. In colon cancer CEA was elevated in 38.4, 46.2, 60 percent of patients with Dukes Stages B, C, and D, respectively. In rectal cancer CEA was elevated in 12.5, 31.6, 44.8, 84.6 percent of patients with Dukes Stages A, B, C, and D, respectively. In Stages B, and C, sensitivity of CEA was higher in colon than in rectal cancer, but the difference was not significant. In Stages D, sensitivity of CEA was higher in rectal cancer than in colon cancer, but the difference was not significant. In overall stages sensitivity of CEA was higher in colon than in rectal cancer, but the difference was not significant. The difference was not significant either in overall or in different stages of colon and rectal cancer.
Carcinoembryonic Antigen
;
Colon*
;
Colonic Neoplasms
;
Humans
;
Rectal Neoplasms*
6.The Clinical Characteristics of Mycoplasmal Pneumonia in Adults.
Jin Ho KIM ; Doo Seop MOON ; Dong Suck LEE ; Ik Soo PARK ; Kyeung Sang LEE ; Ho Joo YOON ; Dong Ho SHIN ; Sung Soo PARK ; Jung Hee LEE
Tuberculosis and Respiratory Diseases 1995;42(2):175-183
BACKGROUND: The incidence of mycoplasmal pneumonia is predominantly at childhood and early adulthood, but in adults, its incidence is low and its symptoms and physical findings are nonspecific. The definite diagnosis of M. pneumoniae pneumonia can be made by sputum culture, but requires several weeks for positive results, and the early diagnosis must initially be based on the serologic tests and appropriate clinical findings. Thus, we evaluated the clinical aspects of M. pneumoniae pneumonia in the adults patients. METHOD: Among the admitted patients due to pneumonia, the definite diagnosis is anti-M. pneumoniae antibody titer of > 1:40 and a single cold agglutinin titer of > 1:64. The presumptive diagnosis is anti-M. pneumoniae antibody titer of > 1:40 or a single cold agglutinin titer of > 1:64 and the clinical characteristics or chest X-ray findings are compatible with M. pneumoniae pneumonia. We studied the age and sex distribution, seasonal distribution, clinical symptoms, physical findings, serologic test, chest X-ray findings, treatment and its progression. RESULTS: 1) The age distribution was even and the ratio of male to female was 1:1. 2) The monthly distribution was most common in January(16.7%) and the seasonal distribution in autumn and winter(autumn: 30%, winter: 33.3%). 3) The cold agglutinin titers were higher than 1:64 in 12 cases(40%), and reached the peak level around 2 weeks from onset and antimycoplasma antibody titers were higher than 1:160 in 5 cases(16.7%). 4) On the chest X-ray, pulmonary infiltration was noted in 28 cases(93.3%) among 30 cases and right lower lobe involvement was the most common(33.3%) and both lower lobe involvement was noted in 7 cases(23.3%). 5) The mean treatment duration was most common(33.3%) in 1 week to 2 weeks after admission and 26 cases(86.7%) were improved within 4 weeks. 6) On admission, there was fever(> or =38.9degreesC) in 17 cases(56.7%), and the fever subsided in 12 cases(70%) within 3 days after treatment using erythromycin. CONCLUSION: The mycoplasmal pneumonia in adults shows milder clinical patterns than that in childhood and can be completely recovered without complication by early diagnosis and treatment.
Adult*
;
Age Distribution
;
Diagnosis
;
Early Diagnosis
;
Erythromycin
;
Female
;
Fever
;
Hospital Distribution Systems
;
Humans
;
Incidence
;
Male
;
Pneumonia*
;
Seasons
;
Serologic Tests
;
Sex Distribution
;
Sputum
;
Thorax
7.A Case of Chemical Pneumonitis Caused by Acetic acid Fume Inhalation.
Seung Ou NAM ; Doo Seop MOON ; Dong Suck LEE ; Jin Ho KIM ; Ik Soo PARK ; Ho Joo YOON ; Dong Ho SHIN ; Sung Soo PARK ; Jung Hee LEE
Tuberculosis and Respiratory Diseases 1994;41(4):424-428
Many organic and nonorganic agents can cause chemical pneumonitis. Chemical pneumonitis induced by inhalation of acetic acid is a rare clinical condition. As acetic acid is a water soluble agent, it causes chemical irritation to respiratory tract and causes variable symptoms. We experienced a case of acute lung injury due to inhalation of acetic acid fume. A 56-year-old male patient was admitted due to dyspnea with vomiting for one day. After he inhaled acetic acid fume in occupational situation, he had chest tightness, chilling sense, and productive cough. Our case was good response to oxygen inhalation, antibiotics, and systemic steroids.
Acetic Acid*
;
Acute Lung Injury
;
Anti-Bacterial Agents
;
Cough
;
Dyspnea
;
Humans
;
Inhalation*
;
Male
;
Middle Aged
;
Oxygen
;
Pneumonia*
;
Respiratory System
;
Steroids
;
Thorax
;
Vomiting
;
Water
8.A Model of Human Nose and Paranasal Sinuses for the Study of Sinus Ventilation.
Yong Soo JEONG ; Sang Ryul KIM ; Dong Hwan KIM ; Dong Keun JUNG ; Sun Seop CHOI ; In Ho JUNG ; Se Hoon SUH
Korean Journal of Otolaryngology - Head and Neck Surgery 1999;42(9):1124-1128
BACKGROUND AND OBJECTIVES: The pathogenesis of chronic paranasal sinusitis has been gradually clarified, but there have been conflicting arguments on the ventilation of paranasal sinus. The aim of the present study is to establish an objective, quantitative and reproducible method for the investigation of the ventilation of paranasal sinuses. MATERIALS AND METHODS: With the axial images of high resolution computed tomography, a fine model of human paranasal sinus was made. The model was fitted with pressure sensors, and the pressure changes in the nasal cavity, frontal, maxillary and sphenoid sinuses were measured by pressure sensors and digital physiograph during nasopharyngeal respiration. RESULTS: Results demonstrated negative pressures compared to the atmospheric pressure during inspiration and positive pressures during expiration in the sinonasal cavities, and the highest and lowest pressures were measured in the nasal cavity. CONCLUSION: This study introduces another method for the investigation on the sinus ventilation through a model study. And this study model has demonstrated that the ventilation of paranasal sinuses depends on nasal respiration. Furthermore, the method is useful to evaluate the results of nasal and sinus surgeries in the case of an obstructed ostium, deviated septum or hypertrophied turbinates.
Atmospheric Pressure
;
Humans*
;
Nasal Cavity
;
Nose*
;
Paranasal Sinuses*
;
Respiration
;
Sinusitis
;
Sphenoid Sinus
;
Turbinates
;
Ventilation*
9.Efficacy of Ecabet Sodium for Helicobacter pylori Eradication, Combined with Lansoprazole-Based Triple Regimen: A Prospective Study.
Jung Yeon SEO ; Min Jeong KIM ; Kyu Han KO ; Dong Hyun KIM ; Dae Seop LIM ; Hae Ri CHON
Korean Journal of Medicine 2011;80(5):546-552
BACKGROUND/AIMS: Ecabet sodium is used for treating gastric ulcers and gastritis. It exhibits a bactericidal effect against Helicobacter pylori by inhibiting bacterial urease activity. Thus, ecabet sodium has been suggested to improve the efficacy of the H. pylori eradication in patients with peptic ulcers. The aim of this study was to compare the H. pylori eradication rate of lansoprazole-based triple therapy versus lansoprazole-based triple therapy plus ecabet sodium. METHODS: The subjects consisted of 363 H. pylori-positive patients who had undergone eradication therapy from February 2007 to February 2010. In total, 363 patients with H. pylori-positive peptic ulcer disease or symptomatic erosive gastritis received LAC (lansprazole 30 mg b.i.d., amoxicillin 1.0 g b.i.d., clarithromycin 500 mg b.i.d.) or LACE (lansoprazole 30 mg b.i.d., amoxicillin 1.0 g b.i.d., clarithromycin 500 mg b.i.d., ecabet sodium 1 g b.i.d.) for 1 week. Successful eradication was defined as a negative 13Curea breath test 4-5 weeks after treatment completion. RESULTS: H. pylori eradication rates were 81.4% (166/204) in the LAC group and 86.2% (137/159) in the LACE group (p = 0.159). No significant difference in eradication was observed. No significant difference was observed in the side effects experienced by the patients in the two treatment groups. CONCLUSIONS: Our results suggest that adding ecabet sodium did not improve the H. pylori eradication rate significantly in standard lansoprazole-based triple therapy for H. pylori.
Amoxicillin
;
Breath Tests
;
Clarithromycin
;
Diterpenes, Abietane
;
Gastritis
;
Helicobacter
;
Helicobacter pylori
;
Humans
;
Peptic Ulcer
;
Prospective Studies
;
Sodium
;
Stomach Ulcer
;
Urease
10.4 cases of multiple symmetric lipomatosis.
Hee Jin JUNG ; Eun Jong LEE ; Yong Hyun KIM ; Sang Jin KIM ; Yeon Soo KIM ; Jae Myung YU ; Sei Hyun BAIK ; Dong Seop CHOI
Korean Journal of Medicine 1993;45(3):407-413
No abstract available.
Lipomatosis, Multiple Symmetrical*